FDA Clearance Tracker · P020045
7F FREEZOR CARDIAC CRYOABLATION CATHETER AND CCT.2 CRYOCONSOLE SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 17, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Apr 17, 2003
Approved
Time to decision
176 days
Received Oct 23, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P020045
- Device name
- 7F FREEZOR CARDIAC CRYOABLATION CATHETER AND CCT.2 CRYOCONSOLE SYSTEM
- Applicant
- Medtronic Cryocath, LP
- Applicant location
- Mounds View, MN
- Received
- Oct 23, 2002
- Decided
- Apr 17, 2003
- Decision
- Approved
- Supplements
- 102 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE 7F FREEZOR CARDIAC CRYOABLATION CATHETER AND CCT.2 CRYOCONSOLE SYSTEM. THE DEVICE IS INDICATED FOR THE CRYOABLATION OF THE CONDUCTING TISSUES OF THE HEART IN THE TREATMENT OF PATIENTS WITH ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA (AVNRT).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Cryocath, LP
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P100010-S110 · Decided Jun 18, 2021 · 231 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
K202620 · Decided Nov 13, 2020 · 64 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
- Arctic Front Advance, Arctic Front Advance Pro and Freezor MAX Cardiac Cryoablation CathetersPMA supplement
P100010-S098 · Decided Jun 23, 2020 · 242 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.